BRIEF-Array BioPharma to discontinue MILO study in ovarian cancer By: Reuters: Company News April 01, 2016 at 09:08 AM EDT * Array BioPharma announces decision to discontinue MILO study in ovarian cancer Read More >> Related Stocks: Array Technologies Inc